These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9617591)

  • 21. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hexavalent combined vaccination].
    Swennen B; Lévy J
    Rev Med Brux; 2004 Sep; 25(4):A212-8. PubMed ID: 15516043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of routine infant rotavirus immunisation program in Japan.
    Hoshi SL; Kondo M; Okubo I
    Hum Vaccin Immunother; 2017 May; 13(5):1115-1125. PubMed ID: 27763810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The further and future evolution of the New Zealand Immunisation Schedule.
    Reid S
    N Z Med J; 2012 May; 125(1354):86-99. PubMed ID: 22595928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of the New Zealand childhood immunisation schedule from 1980: a personal view.
    Reid S
    N Z Med J; 2006 Jun; 119(1236):U2035. PubMed ID: 16807578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
    Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
    Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considering economic analyses in the revision of the preventive vaccination law: a new direction for health policy-making in Japan?
    Akazawa M; Yongue J; Ikeda S; Satoh T
    Health Policy; 2014 Oct; 118(1):127-34. PubMed ID: 25139708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From the Centers for Disease Control and Prevention. Childhood vaccines--United States, 1995-1999.
    JAMA; 2001 Dec; 286(24):3073-4. PubMed ID: 11787489
    [No Abstract]   [Full Text] [Related]  

  • 33. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights from global data for use of rotavirus vaccines in India.
    Rao TS; Arora R; Khera A; Tate JE; Parashar U; Kang G;
    Vaccine; 2014 Aug; 32 Suppl 1():A171-8. PubMed ID: 25091672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2015.
    Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Dietz V
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(39):1065-1071. PubMed ID: 27711036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of state policies on vaccine coverage by age 13 in an insured population.
    Olshen E; Mahon BE; Wang S; Woods ER
    J Adolesc Health; 2007 May; 40(5):405-11. PubMed ID: 17448397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.